FlowMetric Diagnostics

Ren Capocasale

Ren Capocasale

Chairman of the Board, FlowMetric Diagnostics

Rens head shot

Renold has over 20 years of experience in pharmaceutical research and development. He is an expert in polychromatic flow cytometry, cell sorting and immunology-based assay development. Renold is Founder and CEO of FlowMetric Inc., a leader in flow cytometry and cell sorting services.

Prior to establishing FlowMetric, Renold worked for over 13 years at Centocor, a subsidiary of Johnson and Johnson. He established the polychromatic flow facility at Centocor to perform polychromatic flow cytometry and cell sorting. His work at Centocor earned him five prestigious Johnson & Johnson awards for scientific excellence and innovation. He has worked on marketed compounds, Remicade® and Stelara®.  Renold has authored more than 30 peer reviewed scientific manuscripts and publications. He is co-author of one US Patent and has been invited to speak at International Conferences. He has also co-authored a chapter on the “Application of Flow Cytometry in Drug Development” for Immunotoxicology Strategies for Pharmaceutical Safety Assessment, published by John Wiley & Sons in August 2008.

Renold earned his undergraduate degree from Villanova University. Renold is also a board member of iPraxis, a not-for-profit educational organization focused on science and technology education, is a member of the Board of Trustees for Neumann University and an Adjunct Professor at Drexel University College of Medicine.

rcapocasale@flowmetric.com     |     LinkedIn